Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
NCT05951179
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
131
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-muscle Invasive Bladder Cancer
Interventions
BIOLOGICAL:
TARA-002
Sponsor
Protara Therapeutics